ID
38143
Description
Study ID: 111539 Clinical Study ID: 111539 Study Title: A Single-Blind Study of the Safety, Pharmacokinetics and Pharmacodynamics of scalating Repeat Doses of GSK249320 in Patients With Stroke Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00833989 https://clinicaltrials.gov/ct2/show/NCT00833989 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Refanezumab, Placebo Trade Name: N/A Study Indication: Ischaemic Attack, Transient The study consists of 8 visits: Day 1, Week 1 (Day 5), Week 2 (Day 10), Week 4 (Day 30), Week 8 (Day 60), Week 12 (Day 90), Week 16 (Day 112), Follow-up (F/U). All subjects will receive two doses. The first dose within 24-72 hrs after stroke the second dose 9 +/- 1 days after the first one. Each dose will be given as an intravenous infusion over 60 minutes. This document contains the concomitant medication form. It has to be filled in if concomitant medication has been taken by subject.
Lien
https://clinicaltrials.gov/ct2/show/NCT00833989
Mots-clés
Versions (2)
- 22/09/2019 22/09/2019 -
- 05/10/2019 05/10/2019 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
22 septembre 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Safety, Pharmacokinetics and Pharmacodynamics of Refanezumab in Patients with Stroke, 111539
Concomitant medication
- StudyEvent: ODM
Description
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Description
Sequence Number
Type de données
integer
Alias
- UMLS CUI [1]
- C2348184
Description
(Trade Name preferred)
Type de données
text
Alias
- UMLS CUI [1,1]
- C2360065
- UMLS CUI [1,2]
- C2347852
Description
Total daily dose
Type de données
integer
Alias
- UMLS CUI [1,1]
- C2348070
- UMLS CUI [1,2]
- C2347852
Description
Units of concomitant medication
Type de données
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0439148
Description
Route of concomitant medication
Type de données
text
Alias
- UMLS CUI [1]
- C2826730
Description
Reason for Medication
Type de données
text
Alias
- UMLS CUI [1]
- C2826696
Description
day month year
Type de données
date
Alias
- UMLS CUI [1]
- C2826734
Description
Concomitant medication prior to study
Type de données
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C1883727
- UMLS CUI [1,3]
- C0332152
- UMLS CUI [1,4]
- C2347804
Description
If you tick No, please specify End date in the following item.
Type de données
text
Alias
- UMLS CUI [1]
- C2826666
Description
day month year
Type de données
date
Alias
- UMLS CUI [1]
- C2826744
Similar models
Concomitant medication
- StudyEvent: ODM
C2347852 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C0439148 (UMLS CUI [1,2])
C1883727 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C2347804 (UMLS CUI [1,4])